Joshua T Brumm's Net Worth
$20.3 Million
Who is Joshua T Brumm?
Joshua T Brumm has an estimated net worth of $20.3 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., Kaleido Biosciences, Inc., Zeltiq Aesthetics Inc, Versartis, Inc., and PHARMACYCLICS INC.
SEC CIK
Joshua T Brumm's CIK is 0001528826
Past Insider Trading and Trends
2022 was Joshua T Brumm's most active year for acquiring shares with 7 total transactions. Joshua T Brumm's most active month to acquire stocks was the month of November. 2023 was Joshua T Brumm's most active year for disposing of shares, totalling 13 transactions. Joshua T Brumm's most active month to dispose stocks was the month of May. 2022 saw Joshua T Brumm paying a total of $216,300.00 for 832,435 shares, this is the most they've acquired in one year. In 2022 Joshua T Brumm cashed out on 472,025 shares for a total of $3,014,079.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.94
CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.96% | -16.39K |
$15.72 | -$8,835,855.94 | 538K |
Mar 8 - Mar 11
| |||
Form 4
| -1.61% | -9.09K |
$25.85 | -$234,873.10 | 554.38K |
Mar 7
| |||
Form 4
|
—
|
0
|
$17.25 | -$2,341,518.50 | 563.47K |
Feb 29 - Mar 1
| |||
Form 4
| -3.68% | -21.50K |
—
|
—
| 563.47K |
Jan 29
| |||
Form 4
|
—
|
0
|
$11.52 | -$3,853,104.61 | 584.97K |
Jan 3 - Jan 4
| |||
Form 4
| -1.28% | -7.58K |
$10.72 | -$81,311.20 | 584.97K |
Dec 11
| |||
Form 4
| +153.58% | 358.88K |
—
|
—
| 592.56K |
Nov 15
| |||
Form 4
| -4.90% | -12.03K |
$9.41 | -$113,221.12 | 233.68K |
Sep 18
| |||
Form 4
| -3.03% | -7.67K |
$10.41 | -$79,865.52 | 245.71K |
Sep 12
| |||
Form 4
| -21.43% | -69.10K |
$6.97 | -$3,909,425.74 | 253.38K |
Jun 8 - Jun 12
| |||
Form 4
| -2.22% | -7.32K |
$13.33 | -$97,548.94 | 322.48K |
Scheduled
|
Mar 14
| ||
Form 4
| +74.38% | 140.68K |
$10.87 | -$36,110.14 | 329.8K |
Scheduled
|
Dec 9 - Dec 12
| ||
Form 4
| -7.57% | -15.50K |
$6.78 | -$2,413,222.00 | 189.12K |
Oct 7 - Oct 10
| |||
Form 4
| -5.47% | -11.84K |
$13.70 | -$162,153.20 | 204.62K |
Scheduled
|
Sep 20
| ||
Form 4
| -1.58% | -3.48K |
$14.05 | -$48,894.00 | 216.46K |
Scheduled
|
Sep 15
| ||
Form 4
| +6.36% | 13.15K |
$8.24 | -$90,335.12 | 219.94K |
Scheduled
|
Jul 5 - Jul 6
| ||
Form 4
| -1.68% | -3.54K |
$4.95 | -$17,523.00 | 206.78K |
Scheduled
|
Jun 14
| ||
Form 4
| -1.58% | -3.38K |
$8.73 | -$29,542.32 | 210.32K |
Scheduled
|
Mar 11
| ||
Form 4
| +123.74% | 118.19K |
—
|
—
| 213.71K |
Dec 10
| |||
Form 4
| -3.53% | -3.50K |
—
|
—
| 95.52K |
Oct 1
| |||
Form 4
| -7.48% | -8.01K |
$15.90 | -$127,312.49 | 99.02K |
Scheduled
|
Sep 20 - Sep 21
| ||
Form 4
|
∞
| 107.03K |
—
|
—
| 107.03K |
Sep 16 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zeltiq Aesthetics Inc No price found
VP Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.69K |
—
|
—
| 7.69K |
Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Versartis, Inc. (ARAV) No price found
COO and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.65% | -1.33K |
$2.55 | -$3,381.30 | 201.27K |
Oct 19
| |||
Form 4
| +91.86% | 97K |
—
|
—
| 202.59K |
Oct 6
| |||
Form 4
| -1.33% | -1.42K |
$16.05 | -$22,807.05 | 105.59K |
Jun 13
| |||
Form 4
| -1.17% | -1.26K |
$17.40 | -$21,976.20 | 107.02K |
May 16
| |||
Form 4
|
—
|
0
|
$11.74 | -$552,162.71 | 105.78K |
Scheduled
|
Feb 24
| ||
Form 4
| +63.18% | 40.95K |
$13.85 | -$40,794.14 | 105.78K |
Jan 27 - Jan 30
| |||
Form 4
| -1.50% | -990.00 |
$15.85 | -$15,691.50 | 64.82K |
Dec 27
| |||
Form 4
| -4.39% | -3.02K |
$13.25 | -$40,028.25 | 65.81K |
Dec 7
| |||
Form 4
| +17.00% | 10K |
—
|
—
| 68.83K |
Oct 11
| |||
Form 4
| -2.40% | -1.45K |
$10.63 | -$15,392.24 | 58.84K |
Jun 15
| |||
Form 4
| -2.06% | -1.26K |
$7.87 | -$9,955.55 | 60.28K |
May 20
| |||
Form 4
| +73.14% | 26K |
—
|
—
| 61.55K |
Jan 28
| |||
Form 4
| -2.71% | -990.00 |
$12.44 | -$12,311.64 | 35.55K |
Dec 30
| |||
Form 4
| +7.34% | 2.5K |
$9.99 | $24,975.00 | 36.54K |
Nov 12
| |||
Form 4
| -7.09% | -2.60K |
$18.51 | -$48,077.80 | 34.04K |
Jun 11
| |||
Form 4
| +39.88% | 10.45K |
—
|
—
| 36.63K |
Dec 26
| |||
Form 4
| +150.00% | 15K |
—
|
—
| 25K |
Jun 11
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHARMACYCLICS INC No price found
EVP, Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||